Clinical and Radiographic Assessment of Nano-Bioactive Glass Combined With I-PRF Scaffold in Vital Pulp Treatments in Mandibular Molars With Closed Apices

NCT ID: NCT05876520

Last Updated: 2023-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-25

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Clinical, Radiographic and pain assessment of Vital pulp treatment in patients suffering from irreversible pulpitis in mature permanent molars. Total pulpotomy is investigated using I-prf only vs I-prf mixed with Nano-bioactive glass.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vital Pulp Treatment in Mature Permanent Teeth With Irreversible Pulpitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Total Pulpotomy in mature permanent teeth treated with Nano-bioactive glass mixed with I-PRF
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Total pulpotomy with I-PRF only

Total pulpotomy is done in mature permanent molars followed by I-prf application. Topped with BC putty for coronal seal, RMGI and restored with composite as final restoration

Group Type OTHER

Total pulpotomy with I-prf mixed with Nano-bioactive glass

Intervention Type PROCEDURE

Total pulpotomy is done in mature permanent molars followed by I-prf mixed with Nano-Bioactive glass application. Topped with BC putty for coronal seal, RMGI and restored with composite as final restoration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Total pulpotomy with I-prf mixed with Nano-bioactive glass

Total pulpotomy is done in mature permanent molars followed by I-prf mixed with Nano-Bioactive glass application. Topped with BC putty for coronal seal, RMGI and restored with composite as final restoration

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
* Tooth should give positive response to cold test
* Haemostasias should be achieved after total pulpotomy
* The tooth is restorable and free from advanced periodontal disease, cracks and splits.
* Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
* Patients who will agree to the consent and will commit to follow-up period.
* Patients with mature root apices
* Patients with no internal or external resorption and no periapical lesions
* Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion Criteria

* Patients with immature roots.
* Haemostasias after 10 minutes can not be controlled after total pulpotomy
* Patients with any systemic disease that may affect normal healing.
* Patients with periapical lesions or infections.
* Pregnant females.
* Patients who could/would not participate in a 6 months follow-up.
* Patients with fistula or swelling
* Patients with necrotic pulp.
* Patients with old age.
Minimum Eligible Age

14 Years

Maximum Eligible Age

32 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Noor Mohammed Kamal Eldeen Ahmed Mohmammed Sayed

Resident of Endodontics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Geraldine Ahmed

Role: STUDY_DIRECTOR

Vice Dean of Faculty of Dentistry Cairo University

Ahmed S. Elsheshtawy

Role: STUDY_CHAIR

Lecturer of Endodontics

Ayah Abdolwahab

Role: STUDY_CHAIR

Lecturer of Biomaterials

Noor K. Sayed

Role: PRINCIPAL_INVESTIGATOR

Resident of Endodontics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Noor Mohammed Kamal Eldeen

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Noor K. Sayed

Role: CONTACT

00201121818177

Kamal K. Ahmed

Role: CONTACT

0020 101 4147393

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Noor K. Sayed

Role: primary

00201121818177

Noor K. Sayed

Role: backup

00201121818177

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ENDO-3-7-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

New Vital Pulpotomy Medications in Primary Molars
NCT05937100 ACTIVE_NOT_RECRUITING NA